We are live on
!
Find out more
MFA
McClarren Financial Advisors Portfolio holdings
AUM
$193M
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+6.51%
1 Year Est. Return
+20.22%
3 Year Est. Return
+55.32%
5 Year Est. Return
+54.08%
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$10.9M
(+10%)
Cap. Flow
+$3.09M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
57.57%
Holding
491
New
18
Increased
175
Reduced
61
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$488K |
| 2 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$451K |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$378K |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$363K |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$290K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$421K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$300K |
| 3 |
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
|
+$257K |
| 4 |
BLD
TopBuild
BLD
|
+$220K |
| 5 |
Dimensional US Large Cap Value ETF
DFLV
|
+$165K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.26% |
| 2 | Consumer Staples | 1.89% |
| 3 | Industrials | 1.81% |
| 4 | Healthcare | 1.55% |
| 5 | Financials | 1.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Voya Financial
VOYA
$9.19B
| $0 | ﹤0.01% |
4
| – | – |
|
477
Vertex Pharmaceuticals
VRTX
$126B
| $0 | ﹤0.01% |
1
| – | – |
|
478
Warner Bros
WBD
$67.1B
| $0 | ﹤0.01% |
29
| – | – |
|
479
XP
XP
$8.39B
| – | – |
-3
| Closed | – |
|
480
Zoom
ZM
$30.6B
| $0 | ﹤0.01% |
14
| – | – |
|
481
Zscaler
ZS
$27.3B
| – | – |
-3
| Closed | – |
|
|
CTLT
482
DELISTED
CATALENT, INC.
CTLT
| – | – |
-3
| Closed | – |
|
|
PXD
483
DELISTED
Pioneer Natural Resource Co.
PXD
| $0 | ﹤0.01% |
3
| – | – |
|
|
ABCM
484
DELISTED
Abcam PLC
ABCM
| – | – |
-10
| Closed | – |
|
|
SYNH
485
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-3
| Closed | – |
|
|
FRC
486
DELISTED
First Republic Bank
FRC
| – | – |
-5
| Closed | – |
|
|
HZNP
487
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $0 | ﹤0.01% |
3
| – | – |
|
|
CTIC
488
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| – | – |
-553
| Closed | -$2K |
|
|
SIVB
489
DELISTED
SVB Financial Group
SIVB
| – | – |
-1
| Closed | – |
|
|
SBNY
490
DELISTED
Signature Bank
SBNY
| – | – |
-1
| Closed | – |
|
|
DOC
491
DELISTED
PHYSICIANS REALTY TRUST
DOC
| – | – |
-10
| Closed | – |
|
Similar funds
EAM
SCPM
DF
SCM
TVM
IA
CA
OCA
McClarren Financial Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, McClarren Financial Advisors held 491 positions worth $121M, up 10% from $110M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
McClarren Financial Advisors's Q2 2023 filing shows 18 new, 175 increased, 61 reduced and 109 closed positions. Its largest new stake was Schwab Short-Term US Treasury ETF: 14,962 shares worth $359K. The largest sale was Vanguard Short-Term Inflation-Protected Securities Index Fund, an estimated $421K.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Staples and Industrials.
- McClarren Financial Advisors's largest Q2 2023 buy was Schwab Short-Term US Treasury ETF: 14,962 shares worth $359K.
- McClarren Financial Advisors added most to Vanguard Morningstar Mid-Cap ETF in Q2 2023, an estimated $488K increase.
- McClarren Financial Advisors's biggest Q2 2023 reduction was Vanguard Short-Term Inflation-Protected Securities Index Fund, cutting an estimated $421K.
- McClarren Financial Advisors fully exited John Hancock Multifactor Large Cap ETF in Q2 2023, selling an estimated $135K.
- McClarren Financial Advisors's ten largest holdings make up 58% of its $121M portfolio in Q2 2023.
- McClarren Financial Advisors opened 18 new positions and closed 109 in Q2 2023.
- McClarren Financial Advisors's portfolio value rose 10% quarter-over-quarter to $121M.
Based on McClarren Financial Advisors's 13F filing for Q2 2023, filed 7 Aug 2023.